« Back to results
  • Added 8 Aug 2015
  • Expires

Request for Partnership on Application and Implementation of a Trial Grant.


The intended trial is to be conducted on Jobelyn, our novel product that has shown very promising potentials in addressing Poverty Related Diseases (PRDs) like HIV, Trypanosomiasis by optimizing the efficacy of existing therapeutics when used as adjuvant treatment. The grant which is offered by European and Developing Countries Clinical Trials Partnership (EDCTP) and has its link below requires Consortia comprising a minimum of three different legal entities to apply. Two of the legal entities must be established in two different European Participating States(2) of the EDCTP Association. http://www.edctp.org/call/improved-treatment-clinical-management-poverty-related-diseases/

Inclusion Criteria

HIV-1 seropositive adult males or females, confirmed by Western Blot or a licensed double ELISA procedure, antiretroviral drug naïve, and whose baseline haematological, clinical chemistry, CD4+ lymphocyte counts have been evaluated and Viral loads quantified or specimen already taken.

Further information

Legal entities in the following European countries: Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, and the United Kingdom.


Health Forever Product Limited Office Address : 11 Dipeolu Street, Off Obafemi Awolowo Way, Ikeja Lagos State, Nigeria Telephone : +234 803 565 7284; 807 851 6953; 909 640 5190 E-Mail : getinfo@health-forever.com

Respond to this study

Please Login to respond to a study.